• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, June 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Events Conferences International

New Zealand addresses cataract surgery ‘postcode lottery’

by Staff Writer
July 11, 2023
in Cataract, Eye disease, International, News
Reading Time: 3 mins read
A A
Royal Australasian College of Surgeons

RACS oversees nine surgical divisions, but it also has fellows in obstetrics and gynaecology and ophthalmology. Image: Try_my_best/Shutterstock.com

Share on FacebookShare on Twitter

New Zealand is aiming to deliver 3,500 more cataract surgeries as part of a new nationally consistent threshold that removes “the postcode lottery” that has denied some New Zealanders access to this life-changing procedure, the government has announced.

In the recent budget Minister of Health Dr Ayesha Verrall said $118 million was allocated to reduce wait lists and standardise access to healthcare, including cataract surgery.

“Ophthalmologists and patients across the country have been calling for consistency around life-improving cataract surgery and the revised threshold I’m announcing today responds to that,” she said.

“For decades the former DHBs used a point system that had wildly differing thresholds for access to cataract surgery – largely varying from 46 to 61 points. A score of 46 represents mildly reduced vision. A score of 61 represents poor vision and meant that the person could no longer legally drive.”

In Auckland and Waitematā, for example, patients become eligible for cataract surgery with a score of 46. But in Canterbury and Southern, people needed a score of 61.

That variation represented the worst of what’s become widely known as ‘post code’ health, Verrall said.

“In a first under the new health system there will be a nationally consistent score of a maximum of 46 in order to access surgery, opening up eligibility for approximately 3,500 more surgeries,” she said.

“A score of 46 means patients with mildly reduced vision as a result of cataracts will have much earlier access to surgery, improving their quality of life considerably.”

Te Whatu Ora’s Hospital and Specialist team will work with referrers to identify who will be eligible for surgery under the new score and ensure they have timely access to the procedure.

“Today’s announcement is a first in what we can expect to see across elective surgeries from now on; a joined-up health system working towards timely consistent access to healthcare regardless of where you live,” Verrall said.

“We will now be able to use and build on this revised cataract surgery threshold as a model to improve other waitlists into the future.”

Although the news was widely welcomed, ophthalmologists have raised concerns about whether public hospitals would be able to cope with increased demand.

To cater for the new demand, the government is implementing initiatives such as outsourcing to other providers and ophthalmologists, as well as improving productivity through innovative models of care, and improving theatre efficiency.

“Hospitals will probably need to allocate some resources just to cataracts, which in a stretched service might reduce access to other types of eye surgery,” Dr Jesse Gale told Radio NZ on behalf of RANZCO.

He said the plan to outsource some operations to private ophthalmologists could be effective as long as the price was right. But he wasn’t sure how the government was going to improve productivity when all public hospitals were working hard to be as efficient as possible.

More reading

Action needed as NSW lags behind in cataract surgery wait time

Global Alcon cataract survey finds patients need more education

Cataract surgery: Why patient reported outcome measures matter

Related Posts

With support from The Fred Hollows Foundation, Chanthoeun from Cambodia received a pair of special prescription glasses to help with her high myopia and she now conducts basic eyesight tests for her children using skills she learned at the vision centre. Image: Michael Amendolia.

Lancet: Glasses still out of reach for millions of people

by Staff Writer
June 24, 2025

New data released in The Lancet Global Health by the Vision Loss Expert Group and World Health Organisation (WHO) and supported by...

Chris Hodge, Janine Hardy, Hannah Guan, Sasha Kairouz, Sophia Hadwani and Tram Nguyen will be at the IOC representing VEI. Image: VEI.

VEI supporting future of orthoptics at IOC in Brisbane

by Rob Mitchell
June 23, 2025

Vision Eye Institute (VEI) is furthering its already strong support of orthoptists as Platinum Partner for this week’s International Orthoptic...

Dr William Blase assessing scans obtained on the Optos MonacoPro. Images: Image: California Eye Professionals & Optos.

Early insights into the new Optos MonacoPro

by Staff Writer
June 23, 2025

Optos’ latest system is so new that Insight took its search global to find an ophthalmologist who has installed the...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited